Scarica l'app Stockscreener
1.19
3.48%
0.04
Pre-mercato:
1.16
-0.03
-2.52%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CTXR Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.15
Aprire:
$1.18
Volume 24 ore:
322.22K
Relative Volume:
0.39
Capitalizzazione di mercato:
$20.24M
Reddito:
-
Utile/perdita netta:
$-39.14M
Rapporto P/E:
-0.1993
EPS:
-5.97
Flusso di cassa netto:
$-28.20M
1 W Prestazione:
+0.85%
1M Prestazione:
-11.85%
6M Prestazione:
-23.23%
1 anno Prestazione:
-91.19%
Intervallo 1D:
$1.16
$1.20
Intervallo di 1 settimana:
$1.15
$1.23
Portata 52W:
$0.65
$13.52
Citius Pharmaceuticals Inc Stock (CTXR) Company Profile
Nome
Citius Pharmaceuticals Inc
Settore
Industria
Telefono
(908) 967-6676
Indirizzo
11 COMMERCE DRIVE, CRANFORD, NJ
Confronta CTXR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTXR
Citius Pharmaceuticals Inc
|
1.19 | 19.56M | 0 | -39.14M | -28.20M | -5.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
376.62 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.98 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.37 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
729.76 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
329.84 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Citius Pharmaceuticals Inc Stock (CTXR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-30 | Aggiornamento | D. Boral Capital | Hold → Buy |
| 2021-11-30 | Iniziato | Maxim Group | Buy |
Citius Pharmaceuticals Inc Borsa (CTXR) Ultime notizie
CEO Moves: Is Citius Pharmaceuticals Inc a potential multi baggerJuly 2025 Fed Impact & Consistent Growth Equity Picks - خودرو بانک
Analyzing drawdowns of Citius Pharmaceuticals Inc. with statistical tools2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - newser.com
Bond Watch: What is the earnings history of Third Harmonic Bio IncWeekly Loss Report & Fast Momentum Entry Tips - خودرو بانک
Tech Rally: Is Citius Pharmaceuticals Inc part of any major indexDividend Hike & Community Verified Trade Signals - khodrobank.com
Fund Flows: Can Citius Pharmaceuticals Inc lead its sector in growthNew Guidance & Reliable Trade Execution Plans - khodrobank.com
Geopolitics Watch: How liquid is Citius Pharmaceuticals Inc. stockMarket Volume Report & Smart Investment Allocation Tips - khodrobank.com
What Fibonacci levels say about Citius Pharmaceuticals Inc. rebound2025 Year in Review & Expert Verified Movement Alerts - newser.com
How to build a custom watchlist for Citius Pharmaceuticals Inc.Chart Signals & Weekly High Return Stock Opportunities - newser.com
Real time social sentiment graph for Citius Pharmaceuticals Inc.Layoff News & Accurate Buy Signal Notifications - newser.com
Short Covering: How does Citius Pharmaceuticals Inc perform in inflationary periodsJuly 2025 Spike Watch & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
How to recover losses in Citius Pharmaceuticals Inc. stockJuly 2025 EndofMonth & Reliable Volume Spike Trade Alerts - newser.com
Surprises Report: Is Vox Royalty Corp part of any ETFMarket Volume Summary & Weekly Watchlist of Top Performers - khodrobank.com
Aug EndMonth: Can Australian Oilseeds Holdings Limited sustain its profitabilityJuly 2025 Update & Advanced Swing Trade Entry Alerts - khodrobank.com
Earnings Update: Can Marker Therapeutics Inc. deliver consistent dividendsJuly 2025 Review & Community Trade Idea Sharing Platform - خودرو بانک
Does Citius Pharmaceuticals Inc. fit your quant trading modelJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - newser.com
Analyzing Citius Pharmaceuticals Inc. with risk reward ratio charts2025 Bull vs Bear & Consistent Income Trade Recommendations - newser.com
Price Action: Is Citius Pharmaceuticals Inc stock good for income investorsJuly 2025 Institutional & High Accuracy Swing Entry Alerts - خودرو بانک
Trading Recap: Will CASS outperform tech stocks2025 Market Trends & Weekly Market Pulse Alerts - خودرو بانک
Trading Action: Is Citius Pharmaceuticals Inc. part of any major indexJuly 2025 Sector Moves & Stock Timing and Entry Methods - خودرو بانک
Momentum divergence signals in Citius Pharmaceuticals Inc. chartJuly 2025 Short Interest & Stepwise Entry/Exit Trade Alerts - newser.com
Risk Off: Is Citius Pharmaceuticals Inc benefiting from interest rate changesTrade Exit Summary & Fast Gain Stock Tips - khodrobank.com
Market Leaders: Is Beasley Broadcast Group Inc. a cyclical or defensive stockWatch List & Consistent Return Investment Signals - خودرو بانک
Setup Watch: Can FLNC grow without dilutionMarket Performance Recap & Fast Entry and Exit Trade Plans - خودرو بانک
Real time pattern detection on Citius Pharmaceuticals Inc. stockTrade Risk Assessment & Accurate Technical Buy Alerts - newser.com
Applying Wyckoff theory to Citius Pharmaceuticals Inc. stockInsider Buying & Long Hold Capital Preservation Plans - newser.com
Can Citius Pharmaceuticals Inc scale operations efficientlyPortfolio Value Report & Low Risk Entry Point Guides - خودرو بانک
Volume Summary: What is Citius Pharmaceuticals Incs 5 year growth outlook2025 Volatility Report & AI Enhanced Market Trend Forecasts - خودرو بانک
Investment Review: Is Citius Pharmaceuticals Inc in a long term uptrendMarket Activity Report & Safe Entry Zone Identification - خودرو بانک
What recovery options are there for Citius Pharmaceuticals Inc.Quarterly Trade Report & AI Driven Stock Movement Reports - newser.com
Citius Oncology Completes $9 Million Funding Through Registered Direct Offering and Private Placement - geneonline.com
Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement - Barchart.com
Citius Oncology raises $9 million in stock offering By Investing.com - Investing.com Australia
Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement - Nasdaq
Citius Oncology prices $9 million offering; shares down over 5% - MSN
Citius Oncology Raises $9 Mln Through Direct Offering And Private Placement - Nasdaq
Will Citius Pharmaceuticals Inc. benefit from rate cutsEarnings Miss & Fast Gain Swing Alerts - Lancaster City Council
Citius Oncology raises $9 million in stock offering - Investing.com
Can Citius Pharmaceuticals Inc. scale operations efficientlyInsider Selling & Short-Term High Return Ideas - Lancaster City Council
Citius Pharmaceuticals Inc. Moves Into Overbought Range Analysts Cautious2025 Valuation Update & Reliable Entry Point Alerts - beatles.ru
Is Citius Pharmaceuticals Inc. part of any major index2025 Macro Impact & Verified Entry Point Detection - classian.co.kr
Cannabis Stocks News - marketexclusive.com
Is Citius Pharmaceuticals Inc. a cyclical or defensive stock2025 Risk Factors & Safe Entry Zone Identification - beatles.ru
Does Citius Pharmaceuticals Inc. outperform in volatile markets2025 Key Highlights & Daily Profit Maximizing Tips - خودرو بانک
Citius Pharmaceuticals Inc. stock trend outlook and recovery pathJuly 2025 Rallies & Intraday High Probability Alerts - Newser
Is Citius Pharmaceuticals Inc. a momentum stockQuarterly Performance Summary & Expert Approved Trade Ideas - خودرو بانک
Will Citius Pharmaceuticals Inc. stock go up in YEARWeekly Market Summary & Accurate Entry/Exit Alerts - خودرو بانک
Volume spikes in Citius Pharmaceuticals Inc. stock – what they meanBond Market & Long-Term Safe Investment Plans - Newser
Can volume confirm reversal in Citius Pharmaceuticals Inc.2025 Price Momentum & Risk Controlled Daily Trade Plans - Newser
Should you hold or exit Citius Pharmaceuticals Inc. now2025 Biggest Moves & AI Driven Stock Reports - Newser
Is Citius Pharmaceuticals Inc. stock showing strong momentumEarnings Miss & Precise Entry and Exit Recommendations - خودرو بانک
Is Citius Pharmaceuticals Inc. building a consolidation baseCEO Change & Daily Stock Trend Reports - Newser
Citius Pharmaceuticals Inc Azioni (CTXR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.30%
2.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):